Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-22T21:45:33.279Z Has data issue: false hasContentIssue false

Case 4 - Elderly Man Repeating Questions about Upcoming Appointments

Published online by Cambridge University Press:  09 January 2021

By
Serge Gauthier ,
Mira Chamoun ,
Tharick A. Pascoal ,
Jean-Paul Soucy  and
Pedro Rosa-Neto
Edited by
Pedro Rosa-Neto  and
Serge Gauthier
Pedro Rosa-Neto
Affiliation:
McGill University, Montréal
Serge Gauthier
Affiliation:
McGill University, Montréal
Get access

Summary

A 75-year-old, right-handed man accompanied by his wife presented at initial consultation, with a history of mild difficulties with short-term recall for the past 2 years. Although he wrote down the time and place of upcoming appointments accurately, he repeatedly sought reassurance from his wife about them. He kept rechecking where things had been deposited. There was some hesitation for words during conversations.

Type
Chapter
Information
Case Studies in Dementia
Common and Uncommon Presentations
 , pp. 14 - 17
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Therriault, J, Ng, KP, Pascoal, TA, et al. Anosognosia predicts propagation of default mode network metabolic deficits and clinical progression to dementia. Neurology. 2018;90(11):e932–e939.CrossRefGoogle Scholar
McKhann, GM, Knopman, DS, Chertkow, H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer Dement. 2011;7:263–269.CrossRefGoogle ScholarPubMed
Ismail, Z, Agüera-Ortiz, L, Brodaty, H, et al. The Mild Behavioral Impairment Checklist (MBI-C): a rating scale for neuropsychiatric symptoms in pre-dementia populations. J Alzheimers Dis. 2017;56:929–938.CrossRefGoogle ScholarPubMed
Ismail, Z, Agüera-Ortiz, L, Brodaty, H, et al. Drugs for cognitive loss and dementia. Med Lett Drugs Ther. 2017;59:155–161.Google Scholar
Gauthier, S, Albert, M, Fox, N, et al. Why has therapy development for dementia failed in the last two decades? Alzheimers Dement. 2016;12:60–64.CrossRefGoogle ScholarPubMed
Soucy, JP, Bartha, R, Bocti, C, et al. Clinical applications of neuroimaging in patients with Alzheimer’s disease: a review from the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012. Alzheimer Res Ther. 2013;5(Suppl. 1):S3.CrossRefGoogle Scholar
Bergeron, D, Beauregard, JM, Guimond, J, et al. Clinical impact of a second FDG-PET in atypical/unclear dementia syndromes. J Alzheimers Dis. 2016;49(3):695–705.CrossRefGoogle ScholarPubMed
Klunk, WE, Engler, H, Nordberg, A, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306–319.CrossRefGoogle ScholarPubMed
Laforce, R, Rosa-Neto, P, Soucy, JP, et al. Canadian Consensus guidelines on use of amyloid imaging in Canada: update and future directions from the Specialized Task Force on Amyloid Imaging in Canada (STAG). Can J Neurol Sci. 2016;43:503–512.CrossRefGoogle Scholar
Marquié, M, Normandin, MD, Vanderburg, CR, et al. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue. Ann Neurol. 2015;78:787–800.CrossRefGoogle ScholarPubMed
Maass, A, Landau, S, Baker, SL, et al. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer’s disease. NeuroImage. 2017;157:448–463.CrossRefGoogle ScholarPubMed
Olsson, B, Lautner, R, Andreasson, U, et al. CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15:673–684.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×